|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
Boston,Massachusetts,US
|
|
Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.
Our lead asset is Pridopidine, a first-in-class oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children.
Pridopidine is currently being evaluated for the treatment of Huntington’s disease in our global Phase 3 PROOF-HD trial, and for the treatment of ALS in the Phase 2/3 HEALEY platform trial.
The company is led by Dr. Michael Hayden, MD, PhD, the founder of five biotech companies and previous President of Global R&D and Chief Scientific Officer at Teva. Michael has directed the development of multiple innovative drug products, leading to 35 approvals between 2012-2018.
The Company is based in Naarden, the Netherlands, Herzliya, Israel and Boston, MA in the U.S.
|
Prilenia Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Prilenia email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Prilenia customer service number call here +972 77-5558482 . To contact Prilenia customer service number in your country click here to find.
Limor Ben Har is the CEO of Prilenia. To contact Limor Ben Har email at [email protected], [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.